Citations

Mayo Clinic

Showing 10 of 108599 citations.

Another bidder (BDR) revisits
Kapoor, Prashant

Blood | January 26, 2017 | Volume: 129 | Issue: 4 | Pages: 398-400

10.1182/blood-2016-12-754523 | PMID 28126954 Get It

Burnout, career satisfaction, and well-being among US neurologists in 2016
Busis, Neil A. , Keran, Christopher M. , Levin, Kerry H., Schwarz, Heidi B., Molano, Jennifer Rose V. , Vidic, Thomas R., Kass, Joseph S. , Miyasaki, Janis M. , Sloan, Jeff A. , Cascino, Terrence L., Molano, Jennifer R, Shanafelt, Tait D. , Keran, Christopher M

Neurology | January 26, 2017 | Volume: 88 | Issue: 8 | Pages: 797-808

10.1212/wnl.0000000000003640 | PMID 28122905 Get It

A novel de novo frameshift deletion in EHMT1 in a patient with Kleefstra Syndrome results in decreased H3K9 dimethylation
Blackburn, Patrick R. , Williams, Monique , Cousin, Margot A. , Boczek, Nicole J. , Beek, Geoffrey, Lomberk, Gwen , Babovic‐Vuksanovic, Dusica , Klee, Eric W. , Beek, Geoffrey J, Lomberk, Gwen A, Urrutia, Raul A, Babovic-Vuksanovic, Dusica, Urrutia, Raúl , Lomberk, Gwen L

Molecular Genetics & Genomic Medicine | January 26, 2017 | Volume: 5 | Issue: 2 | Pages: 141-146

10.1002/mgg3.268 | PMID 28361100 Get It

AbstractBackgroundKleefstra Syndrome (KS) (MIM# 610253) is an autosomal dominant disorder caused by haploinsufficiency of euchromatic histone methyltransferase‐1 (EHMT1, GLP). EHMT1 (MIM# 607001) encodes a histone methyltransferase that heterodimerizes with EHMT2 (also known as G9a, MIM# 604599), which together are responsible for mono‐ and dimethylation of H3 lysine 9 (H3K9me1 and ‐me2), resulting in transcriptional repression of target genes.MethodsThis report describes an 18‐year‐old woman with intellectual disability, severely limited speech, hypotonia, microcephaly, and facial dysmorphisms, who was found to have a novel de novo single‐base frameshift deletion in EHMT1.ResultsFunctional studies using patient fibroblasts showed decreased H3K9me2 compared to wild‐type control cells, thus providing a rapid confirmatory test that complements molecular studies.ConclusionWhole exome sequencing revealed a novel frameshift deletion in EHMT1 after a lengthy diagnostic odyssey in this patient. Functional testing using this patient's fibroblasts provides proof‐of‐concept for the analysis of variants of uncertain significance that are predicted to impact EHMT1 enzymatic activity.
Epidemiology of Pediatric Critical Illness in a Population-Based Birth Cohort in Olmsted County, MN
Crow, Sheri, Undavalli, Chaitanya, Katusic, Slavica K., Kandel, Pujan , Murphy, Sinéad, Schroeder, Darrell R. , Watson, R. Scott , Crow, Sheri S, Warner, David O. , Schroeder, Darrell

Pediatric Critical Care Medicine | January 25, 2017 | Volume: 18 | Issue: 3 | Pages: e137-e145

10.1097/pcc.0000000000001084 | PMID 28125547 Get It

Objectives: Investigations of pediatric critical illness typically focus on inpatient cohorts drawn from wide referral areas and diverse healthcare systems. Cohorts amenable to investigating the full spectrum of critical illness as it develops within a community have yet to be studied in the United States. Our objective was to provide the first epidemiologic report of the incidence and presentation of pediatric critical illness within a U.S. population-based birth cohort. Design: Retrospective cohort study. Setting: A geographically defined community (Olmsted, MN) with medical record linkage across all health systems. All ICU services are provided within a single children’s hospital. Patients: A birth cohort of children (n =9,441) born 2003–2007 in Olmsted County, MN. Measurements and Main Results: During the study period, there were a total of 15,277 ICU admissions to Mayo Clinic Children’s Hospital. A total of 577 birth cohort children accounted for 824 of these admissions during the 61,770 person-years of follow-up accumulated. Incidence of first-time ICU admission was 9.3 admits per 1,000 person-years. Admission rates were highest in the first year of life and then declined steadily. Respiratory problems were among the most common reasons for admission at any age and diagnoses reflect changes in health risk factors as children grow and develop over time. After 1 year old, a majority of children admitted have preexisting chronic comorbidities and/or prior ICU stays. In-hospital mortality occurred exclusively in children admitted prior to 5 days of age (n = 4). Seven children died after hospital discharge. Conclusions: This is the first report characterizing critical illness within a population-based birth cohort of U.S. children. The results demonstrate the changing incidence, presentation, and healthcare requirements associated with critical illness across the developmental spectrum as a population of children ages.
Caution: Storage Temperature May Alter Drug’s Efficacy
Huntley, Geoffrey D.

Academic Medicine | January 25, 2017 | Volume: 92 | Issue: 2 | Pages: 221-221

10.1097/acm.0000000000001514 | PMID 28118254 Get It

A Plea to Expand the Scope of Tumor Boards
Young‐Fadok, Tonia M.

JAMA Surgery | January 25, 2017 | Volume: 152 | Issue: 5 | Pages: 460

10.1001/jamasurg.2016.5051 | PMID 28122074 Get It

Optimizing proton pump inhibitor therapy for treatment of nonvariceal upper gastrointestinal bleeding
Worden, Jarett , Hanna, Kirollos S.

American Journal of Health-System Pharmacy | January 25, 2017 | Volume: 74 | Issue: 3 | Pages: 109-116

10.2146/ajhp151032 | PMID 28122752 Get It

Extra-Immunization as a Clinical Indicator for Fragmentation of Care
Darden, Paul M. , Gustafson, Kristina K., Nietert, Paul J. , Jacobson, Robert M.

Public Health Reports® | January 25, 2017 | Volume: 126 | Issue: 2_suppl | Pages: 48-59

10.1177/00333549111260s207 | PMID 21812169 Get It

Objectives. We assessed whether extra-immunization can serve as a clinical indicator for fragmentation of care. Methods. Using public-use files of the 1999–2003 National Immunization Survey, we classified children 19–35 months of age by their vaccination providers for the degree of fragmentation of care as ordered from lowest with one vaccine provider, to increasing fragmentation with multiple providers in one facility type, to multiple providers in more than one facility type. Extra-immunization was defined conservatively based on the year-specific recommendations of the Advisory Committee on Immunization Practices (ACIP) for immunizations due before 18 months of age. Of note, 1999–2003 transitioned from oral to inactivated poliovirus vaccines. Results. The rate for extra-immunization was 9.4% (95% confidence interval [CI] 9.2, 9.7). Of single vaccines, the rate for polio vaccine was highest (5.7%, 95% CI 5.5, 6.0). Extra-immunization was lowest for the 69% of children with only one vaccination provider (6.4%, 95% CI 6.1, 6.7), was higher in children who had more than one vaccination provider with one vaccination facility type (13.9%, 95% CI 13.2, 14.6), and highest with more than one facility type (24.1%, 95% CI 22.5, 25.6). Logistic regression (including race/ethnicity, language, provider type, survey year, and a parent-held immunization record) confirmed that multiple providers (adjusted odds ratio [AOR] = 2.30), multiple facility types (AOR=4.67), Spanish language (AOR=1.29), and race/ethnicity (black AOR=1.16, Hispanic AOR=1.31) were each associated with extra-immunization. Excluding poliovirus vaccine from the analysis, AORs for multiple providers and multiple facility types increased to 3.64 and 8.95, respectively. Conclusions. Extra-immunization is associated with receiving immunizations from multiple providers and multiple facility types.
The Effect of Systemic Triamcinolone Acetonide on Nerve Repair
Bansberg, Stephen F. , McCaffrey, Thomas V.

Otolaryngology–Head and Neck Surgery | January 25, 2017 | Volume: 96 | Issue: 2 | Pages: 158-164

10.1177/019459988709600208 | PMID 3120090 Get It

The effects of timed‐release pellets of triamcinolone acetonide on sciatic nerve regeneration were studied. Bilateral nerve defects were created in 18 rats. One defect was sutured primarily, while the contralateral side was grafted with a 1 cm autogenous graft. Nerve regeneration was assessed at 20 weeks by muscle‐twitch strength and compound action potential parameters measured proximal and distal to the repair site. Conduction velocity and regenerative index (ratio of distal to proximal compound action potential area) were calculated. Significant improvement of the regenerative index and twitch strength occurred in animals treated with a 0.5 mg 21‐day‐release pellet. Improvement occurred in animals treated with 0.5 mg 60‐day pellets, but the difference was not significant. The findings suggest that regeneration was enhanced as a result of increased numbers of axons that made distal connections in the animals that received 21‐day‐release triamcinolone systemically. Corticosteroid therapy may benefit motor nerve repair.
Immunosuppressive Therapy in Heart Transplantation
Li, April Yingfang, Nwankwo, Ifeyinwa S., Huang, Zhi , Lu, Yun , Yao, Yali, Li, Yan , Zhang, Bin

Advances in Medical Diagnosis, Treatment, and Care | January 25, 2017 | Volume: No volume available | Issue: No issue available | Pages: 212-231

10.4018/978-1-5225-2092-4.ch012 Get It

Heart transplantation is a surgical procedure performed on patients with end-stage heart failure or other irreversible heart disease, Heart transplant prolongs the life of severe heart disease patients. Most of the receipts could survive more than 2-3 years, five-year survival rate could reach 70-80% with immunosuppressive therapy, rejection still an important problem after transplantation. Currently, traditional calcineurin inhibitors, antimetabolite agents, and steroids, wildly used after transplantation, the new generation of immunosuppressive medicines have been developed, and cell-based immunotherapy, as mesenchymal stem cell, myeloid-derived suppressor cells, dendritic cells, pluripotent cells and Treg cells are promising to be used in cellular immunotherapy in organ transplantation.